Search
for
Sort by
Research 31–60 of 1000+
- Hair and Nail Disorders in Children with FST 5
- Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol
- [Advances in topical therapy of skin diseases (author's transl)].
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- The Over‐The‐Counter Finasteride Alternative: A Critical Review of Saw Palmetto's Efficacy, Safety, and Regulatory Concerns
- Organic Causes of Erectile Dysfunction in Men Under 40
- Anti-androgenic potential of the fruit extracts of certain Egyptian <i>Sabal</i> species and their genetic variability studies: a metabolomic-molecular modeling approach
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- A New Look at the 5?-Reductase Inhibitor Finasteride
- Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor
- Treatment of chemotherapy-induced alopecia
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- New hair care ingredients
- Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Metabolite identification by mass spectrometry of the 5α-reductase inhibitor finasteride in vitro and in vivo
- Finasteride, a 5α-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat
- Regarding prostate-specific antigen: let's not shoot the messenger
- Saturable Binding of Finasteride to Steroid 5α-reductase as Determinant of Nonlinear Pharmacokinetics
- Pharmacogenetic analysis of human steroid 5α reductase type II: comparison of finasteride and dutasteride
- Hair Are the Rankings—5-α Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia
- VIBRATIONAL SPECTROSCOPIC INVESTIGATION AND MOLECULAR STRUCTURE OF A 5α-REDUCTASE INHIBITOR: FINASTERIDE
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Effects of the anti-androgen finasteride on 5α-reduction of androgens in the presence of progesterone in human gingival fibroblasts: modulatory actions of the alkaline phosphatase inhibitor levamisole
- Assessment of efficacy and safety of dapsone gel 5% in the treatment of acne vulgaris
- T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?
- VIBRATIONAL SPECTROSCOPIC INVESTIGATION AND MOLECULAR STRUCTURE OF A 5α-REDUCTASE INHIBITOR: FINASTERIDE
- Faculty Opinions recommendation of Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study.
- Study on genetic polymorphisms of androgen receptor gene and 5α-reductase genes of Han men with androgenetic alopecia in the Eastern China